510(k) Report

510(k) · Cleared

Recalled · Class II · 2013

Vitros Chemistry Products Cocm Reagent, Calibrator Kit 26, FS Calibrator 1 and Dat Performance Verifiers I, II, Iii, IV

K062123510(k) TraditionalCleared Nov 16, 2006114-day reviewClass II21 CFR 862.3250Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ortho-Clinical Diagnostics, Inc. · DIO Enzyme Immunoassay, Cocaine And Cocaine Metabolites

Cleared on Nov 16, 2006 as substantially equivalent to K031512 (Dade Behring, Inc., 2003) and 1 other predicate after a 114-day review. Its family tree reaches back 2 generations to 2000. It has been recalled once.

Decided
Nov 16, 2006
Review
114 days
Class
Class II
Product code
DIO
Recalls
1
Predicates
2

Its longest line of descent runs back 2 generations to K993988 (2000). 3 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2002: 1 other ancestorK993988 · Syva Emit II Plus Cocaine Metabolite Assay, Model 9H029UL · Syva Co. · 2000K031512 · Emit II Plus Cocaine Metabolite Assay · Dade Behring, Inc. · 200320002002200420062008
Other ancestors, by generation 1 generation back: 1 other ancestor K031512 · Emit II Plus Cocaine Metabolite Assay · Dade Behring, Inc. · 2003K993988 · Syva Emit II Plus Cocaine Metabolite Assay, Model 9H029UL · Syva Co. · 20000
  1. Root · 2 generations backK993988 Syva Emit II Plus Cocaine Metabolite Assay, Model 9H029ULSyva Co. · 2000
  2. 1 generation backK031512 Emit II Plus Cocaine Metabolite AssayDade Behring, Inc. · 2003
  3. This deviceK062123 Vitros Chemistry Products Cocm Reagent, Calibrator Kit 26, FS…Ortho-Clinical Diagnostics, Inc. · 2006
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K993988Syva Emit II Plus Cocaine Metabolite Assay, Model 9H029ULSyva Co.2000—
−1K031512Emit II Plus Cocaine Metabolite AssayDade Behring, Inc.2003—
0 (this device)K062123Vitros Chemistry Products Cocm Reagent, Calibrator Kit 26, FS Calibrator 1 and…Ortho-Clinical Diagnostics, Inc.2006—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200210
FIG. 1 — Lineage of K062123, 2000–2006Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DIO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DIO device

  1. #1 K213211 Carolina Liquid Chemistries Cocaine and…score 3.1 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K031512Emit II Plus Cocaine Metabolite Assay
Summary page 2
…Products COCM assay is substantially Devices equivalent to the previously cleared Syvat Emit" 11 Plus Cocaine Metabolite assay (K031512). The VITROS Chemistry Products DAT Performance Verifiers are substantially equ…
Dade Behring, Inc.2003—
*K022707Liquichek Urine Toxicology Control Level S1E, Model 438; Level S2E, Model 439
Summary page 2
…rifiers are substantially equivalent to the previously cleared LiquichekTM Urine Toxicology Control Levels SIE and S2E (K022707). 5. Device The VITROS COCM assay is a homogeneous enzyme immunoassay description that is performed u…
Bio-Rad2002—

Also cleared against K031512: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Oct 4, 2013Class IIZ-0817-2014OtherInaccurate quality control results.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 6 years and passes through 3 companies; a new generation was cleared every 3.5 years on median.
  • None of the 3 ancestors has a recall.
  • 1 other device also cites its predicate K031512.

How does its category compare?

All DIO devices

DIO Enzyme Immunoassay, Cocaine And Cocaine Metabolites: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DIO

1in 2022

2009: 12011: 52012: 52013: 22014: 22015: 22016: 32017: 32018: 12020: 12021: 12022: 1
2007high 5 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DIO

267in 2017

2011: 65 days median2012: 139 days median2016: 88 days median2017: 267 days median
2007high 267 (2017) · low 65 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DIO

1in 2013

2013: 1
2007high 1 (2013) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DIO

1in 2023

2011: 42014: 12015: 72016: 92017: 162018: 122019: 222022: 12023: 1
2007high 22 (2019) · low 0 (2007)2025

MAUDE reports naming product code DIO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20091—00
20100—00
201156504
2012513900
20132—10
20142—01
20152—07
201638809
20173267016
20181—012
20190—022
20201—00
20211—00
20221—01
20230—01
20240—00
20250—00
20260—0—

What is it indicated for?

For in vitro diagnostic use only. VITROS Chemistry Products COCM Reagent is used on VITROS 5,1 FS Chemistry Systems for the semi-quantitative or qualitative determination of benzoylecgonine (cocaine metabolite) in human urine using a cutoff of either a 150 ng/mL or a 300 ng/mL. Measurements obtained with the VITROS COCM method are used in the diagnosis and treatment of cocaine use or overdose. The VITROS Chemistry Products COCM assay is intended for use…

Read the full statement (222 words)

For in vitro diagnostic use only. VITROS Chemistry Products COCM Reagent is used on VITROS 5,1 FS Chemistry Systems for the semi-quantitative or qualitative determination of benzoylecgonine (cocaine metabolite) in human urine using a cutoff of either a 150 ng/mL or a 300 ng/mL. Measurements obtained with the VITROS COCM method are used in the diagnosis and treatment of cocaine use or overdose.

The VITROS Chemistry Products COCM assay is intended for use by professional laboratory personnel. It provides only a preliminary test result. A more specific alternative chemical method must be used to confirm a result obtained with this assay. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug-of-abuse test result, particularly when evaluating a preliminary positive result.

For in vitro diagnostic use only. VITROS Chemistry Products Calibrator Kit 26 is used to calibrate VITROS 5,1 FS Chemistry Systems for the qualitative or semi-quantitative measurement of drugs of abuse.

For in vitro diagnostic use only. VITROS Chemistry Products FS Calibrator 1 is used in conjunction with VITROS Chemistry Products Calibrator Kits to calibrate VITROS 5,1 FS Chemistry Systems.

For in vitro diagnostic use only. VITROS Chemistry Products DAT Performance Verifiers are assayed controls used to monitor performance of urine drugs of abuse screening assays on VITROS 5,1 FS Chemistry Systems.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K062123: Vitros Chemistry Products Cocm Reagent, Calibrator Kit 26, FS Calibrator 1 and Dat Performance Verifiers I, II, Iii, IV.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K062123

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026